securPharm: Falsified Medicines Directive Will Change The Pharmaceutical Market
About 400 representatives of pharmaceutical companies, wholesalers, pharmacists and their national and international associations participated in the 2nd securPharm European Conference on the Falsified Medicines Directive. securPharm had invited them to this meeting to inform them regarding the implementation status of the Falsified Medicines Directive in Germany and on the status of the European legislative process. Apart from the securPharm experts, speakers included practitioners from the pharmaceutical industry, wholesalers and pharmacies as well as the representatives in charge from the EU Commission and the German Federal Ministry of Health.